Small for Gestational Age at Delivery
22
6
10
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 22 trials
100.0%
+13.5% vs benchmark
14%
3 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (22)
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
BEP Targeting Strategies in Ethiopia
The CanDo (Canadian Donor Milk) Trial
Growing Little PEAPODS Study
MIRACLE of LIFE Study
Improving Birth Outcomes in Bangladesh
Neuromotor Development and Motor Related Health Care in Children with a High Risk Neonatal Period
Bioimpedence and Arterial Function Monitoring at Birth and in Infants
Description and Comparison of Biological Vulnerability in Small Vulnerable Newborns Versus Healthy Community Controls in Urban Burkina Faso
PRECISE - Objective Measures and Observations of Physical Exposures Among Pregnant Employees in the Danish Workforce
Calcium Aspirin Multiple Micronutrients (CAMMS) to Reduce Preterm Birth
Umbilical Cord Abnormalities in the Prediction of Adverse Pregnancy Outcomes
Happy Mother-Healthy Baby: An Anxiety-focused Early Prenatal Intervention
Evaluation of HALP Score in Distinction Between FGR and SGA
Drinking Water PFAS, Pregnancy Outcome and Maternal Morbidity
Omega 3 Plus Vaginal Progesterone on Birth Weight of Constitutionally Small for Gestational Age Fetuses
Effect of a Fortified Balanced Energy-Protein Supplement on Birth Outcome and Child Growth in Houndé District, Burkina Faso.
Fit After Baby: Increasing Postpartum Weight Loss in Women at Increased Risk for Cardiometabolic Disease
Use of Customized GROW Charts for Detection of SGA in Low Risk Woman.